QuantLogix's current estimate for OM1, published 2026-09-27 — in line with the last disclosed round of $855M (2021-Q3).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$855M
2021-Q3
weight 0.03
How this price has held up
No round has priced for OM1 since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, OM1, 2026-09-27 (dcd02843b4d1bc8a).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is OM1 going public?
No. OM1 is private and has not filed to go public. There is no S-1 on file.
What is OM1's valuation in 2026?
OM1 is valued at $855M as of 2021-Q3, set by its Series D ($85M, Jul 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has OM1 filed an S-1?
No public S-1 is on file for OM1.
How much has OM1 raised?
OM1 has raised $176.25M in total, most recently a Series D of $85M in Jul 2021.
Is OM1 publicly traded — can you buy OM1 stock?
No. OM1 is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for OM1 on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2015
HQ
Boston, MA
Employees
119
Total Raised
$176.25M
Last Round
Series D — $85M (Jul 2021)
IPO Status
private
Fundraising Status
Series D · $85M · 5y 2mo ago
privateTotal raised $176.25M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series D
$85M
Jul 2021
—
$855M
Talent Signal
Hiring trend
▶ Hiring steady
0% vs 2026-08
Open roles
6
via careers page
Product-build share
83%
engineering, research, product, design
Trajectory
steady
heavy product build — 83% of open roles are product-building functions (engineering/research/product) — 3 of 6 open roles are medical.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Research ProgramsClinical RegistriesClinical Datasets & Insights[Research Programs](https://www.om1.com/research-programs/)[Clinical Registries](https://www.om1.com/our-solutions/clinical-registries/)Om1 Brand Abstract Blue Image
Counted from OM1's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
MedicalHealth CareInformation TechnologyBig Data
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q3. Refreshed quarterly.